Bacteremia and infection of a hip prosthesis caused by Bacillus alvei, J Clin Microbiol, vol.27, pp.1395-1401, 1989. ,
Paenibacillus konsidensis sp. nov., isolated from a patient, Int J Syst Evol Microbiol, vol.58, pp.2164-2172, 2008. ,
Current knowledge and perspectives of Paenibacillus: a review, Microb Cell Fact, vol.15, p.203, 2016. ,
16S/23S rRNA sequencing, Nucleic acid techniques in bacterial systematics, pp.115-76, 1991. ,
Pseudomonas indica sp. nov., a novel butane-utilizing species, Int J Syst Evol Microbiol, vol.52, pp.1559-67, 2002. ,
Transfer of Bacillus alginolyticus, Bacillus chondroitinus, Bacillus curdlanolyticus, Bacillus glucanolyticus, Bacillus kobensis, and Bacillus thiaminolyticus to the genus Paenibacillus and emended description of the genus Paenibacillus, Int J Syst Bacteriol, vol.47, pp.289-98, 1997. ,
Transfer of Bacillus lentimorbus and Bacillus popilliae to the genus Paenibacillus with emended descriptions of Paenibacillus lentimorbus comb. nov. and Paenibacillus popilliae comb. nov, Int J Syst Bacteriol, vol.49, pp.531-571, 1999. ,
Manual of clinical microbiology, pp.789-97, 2003. ,
, World Health Organization. WHO guidelines on tularaemia. Geneva: The Organization, 2007.
Paenibacillus assamensis sp. nov, Int J Syst Evol Microbiol, vol.55, pp.2577-81, 2005. ,
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, European and Developing Countries Clinical Trial Partnership References, vol.1, pp.437-480, 2015. ,
Ter Kuile FO. Safety, tolerability, and efficacy of repeated doses of dihydroartemisininpiperaquine for prevention and treatment of malaria: a systematic review and meta-analysis, Lancet Infect Dis, vol.17, pp.184-93, 2017. ,
Genetic markers associated with dihydroartemisininpiperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study, Lancet Infect Dis, vol.17, issue.16, pp.30409-30410, 2017. ,
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study, Lancet Infect Dis, vol.17, pp.30415-30422, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01400955
The population genetics of structural variation, Nat Genet, vol.39, pp.30-36, 2007. ,
pfmdr1 amplification is related to increased Plasmodium falciparum in vitro sensitivity to the bisquinoline piperaquine, Antimicrob Agents Chemother, vol.56, pp.3615-3624, 2012. ,
Quantifying the pharmacology of antimalarial drug combination therapy, Sci Rep, vol.6, p.32762, 2016. ,
, Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial, Lancet, vol.391, pp.1378-90, 2018.
Polymorphisms in the K13-propeller gene in artemisininsusceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali, Am J Trop Med Hyg, vol.92, pp.1202-1208, 2015. ,
No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali, Am J Trop Med Hyg, vol.87, pp.12-0058, 2012. ,